Immunotherapies and immunomodulatory approaches in clinical trials - a mini review

The coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created havoc worldwide. Due to the non-availability of any vaccine or drugs against COVID-19, immunotherapies involving convalescent plasma, immunoglobulins, antibodies (monocl...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal Yatoo, Mohd., Hamid, Zeenat, Rather, Izhar, Nazir, Qurat Ul Ain, Bhat, Riyaz Ahmed, Ul Haq, Abrar, Magray, Suhail Nabi, Haq, Zulfqar, Sah, Ranjit, Tiwari, Ruchi, Natesan, SenthilKumar, Bilal, Muhammad, Harapan, Harapan, Dhama, Kuldeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885722/
https://www.ncbi.nlm.nih.gov/pubmed/33577374
http://dx.doi.org/10.1080/21645515.2020.1871295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885722/
https://www.ncbi.nlm.nih.gov/pubmed/33577374
http://dx.doi.org/10.1080/21645515.2020.1871295

Ejemplares similares